Latest News
FEATURED STORY
RTI Surgical Transforms into Evergen, a Leading CDMO in Regenerative Medicine
December 17, 2024RTI Surgical ("the Company"), a leading CDMO pushing the boundaries of innovation and tissue engineering to meet patient needs in regenerative medicine, today unveils its new corporate identity as Evergen, signaling its strategic evolution into a premier Contract Development...
Latest Stories
-
December 17, 2024
RTI Surgical Transforms into Evergen, a Leading CDMO in Regenerative Medicine -
November 25, 2024
RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva® Allograft Dermis in Breast Reconstruction -
November 1, 2024
RTI Surgical Completes Acquisition of Collagen Solutions
Upcoming Events
-
Sep 12 - 14, 2024
American Hernia Society (AHS) -
Sep 25 - 28, 2024
North American Spine Society (NASS) -
Sep 26 - 29, 2024
Plastic Surgery, The Meeting (ASPS) -
Oct 20 - 22, 2024
American College of Surgeons Congress (ACS)
Awards
-
December 7, 2023
RTI Surgical Recognized as 2023 DEI Finalist for Greater Gainesville Area Business Awards -
January 24, 2023
RTI Surgical Recognized as Alachua Chamber's 2022 Large Business of the Year -
December 8, 2022
RTI Surgical Recognized as 2022 DEI Finalist for Greater Gainesville Area Business Awards
Press Releases
-
December 17, 2024
RTI Surgical Transforms into Evergen, a Leading CDMO in Regenerative Medicine -
November 25, 2024
RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva® Allograft Dermis in Breast Reconstruction -
November 1, 2024
RTI Surgical Completes Acquisition of Collagen Solutions